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Abstract The calcium transport A TPase and the copper
transport A TPase are members of the P-A TPase family and
retain an analogous catalytic mechanism for A TP utilization,
including intermediate phosphoryl transfer to a conserved
aspartyl residue, vectorial displacement of bound cation,
and final hydrolytic cleavage of Pi. Both A TPases undergo
protein conformational changes concomitant with catalytic
events. Yet, the two A TPases are prototypes of different
features with regard to transduction and signaling mecha-
nisms. The calcium A TPase resides stably on membranes
delimiting cellular compartments, acquires free Ca
2+ with
high affinity on one side of the membrane, and releases the
bound Ca
2+ on the other side of the membrane to yield a
high free Ca
2+ gradient. These features are a basic
requirement for cellular Ca
2+ signaling mechanisms. On
the other hand, the copper A TPase acquires copper through
exchange with donor proteins, and undergoes intracellular
trafficking to deliver copper to acceptor proteins. In
addition to the cation transport site and the conserved
aspartate undergoing catalytic phosphorylation, the cop-
per A TPase has copper binding regulatory sites on a
unique N-terminal protein extension, and has also serine
residues undergoing kinase assisted phosphorylation.
These additional features are involved in the mechanism of
copper A TPase intracellular trafficking which is required to
deliver copper to plasma membranes for extrusion, and to the
trans-Golgi network for incorporation into metalloproteins.
Isoform specific glyocosylation contributes to stabilization of
A TP7A copper A TPase in plasma membranes.
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Introduction
Transport A TPases of the P-type family are members of the
acid dehalogenases superfamily (Burroughs et al. 2006),
and are membrane bound enzymes whose catalytic cycle
includes A TP utilization by formation of a phosphorylated
enzyme intermediate, vectorial displacement of bound
cation, and final hydrolytic cleavage of Pi from the
phosphoenzyme intermediate. Transport A TPases (Inesi
and Nakamoto 2008) are essential components of numerous
mechanisms pertinent to signaling, homeostasis and energy
metabolism. They are also relevant to diseases of cardiac
muscle, cancer, osteoporosis, retinal degeneration, immune
deficiency, cystic fibrosis, diabetes, gastric ulcer, hearing
loss, skin alterations, and copper-related disorders. Com-
pounds of pharmacological and therapeutic interest, and
their interaction with transport A TPases, such as ouabain,
thapsigargin and gastric H
+ pump inhibitors, have been
recognized. Furthermore, an important role of transport
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apparent.
Within the wide family of ion-motive P-type A TPases, it
is interesting to compare the calcium and the copper
transport A TPases, as they are prototypes of enzymes that
retain basic structural and catalytic features, but at the same
time display prominently diverse features. In fact, the
plasma (Brini and Carafoli 2009) and intracellular Ca
2+
A TPases (de Meis and Vianna 1979; Inesi 1985; Møller et
al. 2010) reside on membranes delimiting distinct cellular
compartments and, in this rather stable position, collect free
Ca
2+ from one side of the membrane to release it on the
other side, yielding a three to four orders of magnitude free
Ca
2+ gradient. On the other hand, copper is acquired by the
copper A TPase (Lutsenko et al. 2007) through exchange
with donor proteins, and is then delivered to acceptor
proteins by vectorial displacement, without formation of
high free copper gradients. In addition, the copper A TPase
undergoes intracellular trafficking to reach rather distant
locations for copper delivery and extrusion.
The calcium ATPase
Calcium A TPases include transporters located on plasma
membranes (PMCA: Brini and Carafoli 2009), on the
Golgi/secretory pathway (Ca
2+/Mn
2+-SPCA: Ton and Rao
2004; V an Baelen et al. 2004), and on Sarco-Endoplasmic
Reticulum membranes (SERCA). The latter is discussed
here due to its detailed characterization. SERCA enzyme
isoforms are encoded by three highly conserved genes
(SERCA1, 2, and 3) localized on different chromosomes,
and undergo alternative splicing following transcription
(Periasamy and Kalyanasundaram 2007). The SERCA1
isoform (MacLennan et al. 1985) has been studied in detail,
and the sequence of reactions and conformational changes
comprising its catalytic and transport cycle is well known.
Its amino acid sequence comprises (Fig. 1) ten transmem-
brane mostly helical segments, where the fourth, fifth, sixth
and eighth segments contribute residues to a Transmembrane
Binding Site (TMBS) for two Ca
2+ required for enzyme
activation and undergoing active transport. The SERCA1
headpiece includes an N domain with the A TP binding site, a
P domain with the aspartyl residue undergoing phosphory-
lation as a catalytic intermediate, and an A domain
containing the conserved TGE motif involved in catalytic
assistance of the final hydrolytic reaction.
From the functional stand point, the equilibrium binding
isotherm (Inesi et al. 1980) shown in Fig. 2 demonstrates
that each molecule of SERCA1 protein binds two Ca
2+ with
high affinity Ka ¼ 3   1012 M2 
and high cooperativity
(Hill coefficient = 1 .82). Mutational analysis has demon-
strated that E309, E771, N796, T799, D800 and E908 in
the transmembrane region (Fig. 1) are specifically required
for Ca
2+ dependent catalytic functions (Clarke et al. 1989;
Andersen and Vilsen 1992), and are directly involved in
Ca
2+ binding (Strock et al. 1998) as elegantly shown by
crystallography (Toyoshima et al. 2000).
The high specificity of the SERCA activating and
transport sites (TMBS) for Ca
2+ is revealed by high
binding affinity and selectivity for Ca
2+ in the presence of
much higher concentrations of Mg
2+ which is required in
conjunction with A TP for phosphoryl transfer at the
catalytic site within the P domain. It is of interest that
Mn
2+ appears able to substitute to some extent for both
Ca
2+ and Mg
2+ (Chiesi and Inesi 1981).
Addition of A TP (Fig. 2) to the calcium activated A TPase
(E1
.Ca2) is rapidly followed by formation of the phosphor-
Fig. 1 Two-dimensional folding
model of the SERCA1 sequence.
The diagram shows ten trans-
membrane segments including
the calciumbinding sites (TMBS)
involved in enzyme activation
and transport. Y ellow residues
contribute side chain oxygen
atoms for calcium binding.
The extramembranous region
comprises: a nucleotide binding
domain (N); the P domain,
with several residues (in red)
conserved in P-type A TPases,
including D351 that undergoes
phosphorylation to form the
catalytic phosphoenzyme inter-
mediate (EP); and the A domain
withtheTGEconservedsequence
involved in catalytic assistance
of EP hydrolytic cleavage
228 G. Inesiylated intermediate (E1-P
. Ca2) and occlusion of the two
bound Ca
2+ that become unavailable for exchange on the
surface of the membrane (Inesi et al. 1980). Isomerization
of the phosphoenzyme (E2-P
. Ca2) is then followed by
vectorial dissociation of the two bound Ca
2+.F i n a l
hydrolytic cleavage of Pi completes the cycle, yielding a
turnover of 2 Ca
2+ pumped per one A TP utilized by the
A TPase. At neutral pH, Ca
2+ binding and dissociation occur
in concomitance with H
+ exchange, as occupancy of
pertinent acidic residues favors the E2 conformation, and
H
+ dissociation favors the E1 state. It is apparent that a pK
change, in parallel with phosphoenzyme isomerization,
contributes to reduction in affinity and dissociation of
bound Ca
2+ (Tadini-Buoninsegni et al. 2006). The sequen-
tial reactions comprising the catalytic and transport cycle
are shown in the following scheme:
The equilibrium constants of the partial reactions listed
in the scheme yield an overall free energy requirement that
matches the standard free energy derived from hydrolytic
cleavage of A TP γ-phosphate (Inesi et al. 1990). It is of
interest that the equilibrium constants for enzyme phos-
phorylation by A TP (reaction 2), as well as the final
hydrolytic cleavage of Pi (reaction 6) are nearly 1,
indicating that the free energy of A TP is conserved by the
enzyme and used to change the Ca
2+ binding characteristics
through conformational work. This means that the chemical
potential of A TP does not manifest itself in the phosphoryl
transfer (A TP
. E
. Ca2 ←→ ADP
. E-P
. Ca2) or hydrolytic
cleavage (H2E-P ←→ H2E
. Pi) reactions, but rather in the
drastic reduction of the enzyme affinity for Ca
2+, as the
enzyme transitions from E
. Ca2. to E2-P
. Ca2 .I fw e
consider that the free energy required for one A TPase cycle
is used to change the equilibrium constant of reaction 1 to
the equilibrium constant of reaction 4, under standard
conditions,
ΔG ¼ RT ln Ka
reaction5=Ka
reaction1 
where Ka
reaction 1 is the association constants of the enzyme
for Ca
2+ in the ground state (H2E+2Caout
2+ ←→ E
. Ca2+
2Hout
+) and and Ka
reaction 5 is the association constant of the
enzyme for Ca
2+ following the phosphoenzyme transition
(H2E-P+2Cain
2+ ←→ E-P
. Ca2+2Hin
+). The corresponding
values, at 25°C and pH 7.0, are 3×10
12 M
2 and 3×10
5 M
2,
yielding a free energy requirement of ∼9 Kcal per cycle
which is used to change Ka
reaction 1 to Ka
reaction 5 .T h i sv a l u e
approximates the expected yield of free energy by cleavage
of A TP γ-phosphate under standard conditions. Free energy
changes in the presence of various concentrations of
substrates and products were subjected to analysis and
explained elsewhere (Inesi et al. 1990). It is of interest that
the entire cycle can be reversed by phosphorylating the
enzyme with Pi in the absence of Ca
2+, and then adding high
(mM) Ca
2+ and ADP to form A TP (Masuda and de Meis
1973). Therefore, chemical and binding energy can be
interconverted in either direction of the cycle, by means of
protein conformational work.
Functional characterization of the SERCA cycle indi-
cates that the basic coupling mechanism of catalysis and
transport consists of mutual destabilization of Ca
2+ and
phosphorylation sites. Considering that the Ca
2+ binding
Fig. 2 Functional characterization of SERCA1. The left panel shows
an equilibrium binding isotherm obtained by incubation of SERCA
with different concentrations of CaCl2 (EGTA-Ca buffer) in the
absence of A TP . The right panel shows a pre-steady state experiment
initiated by addition of A TP to SERCA saturated with Ca
2+. Rapid
formation of phosphorylated intermediate is accompanied by occlu-
sion of bound calcium. Hydrolytic cleavage of Pi occurs following a
lag period and continues with steady state velocity. A TP utilization and
Ca
2+ transport occur with stoichiometric ratio of 1:2. Adapted from
Inesi et al. (1980)
Calcium and copper A TPases: analogies and diversities 229and phosphorylation site are separated by a relatively large
distance (
∼50 Å: Figs. 1 and 3), it is apparent that
interconversion of cation-binding and phosphorylation
potentials requires a long-range intramolecular linkage,
rendered possible by protein conformational changes. To
start with, catalytic activation by Ca
2+ binding produces a
prominent conformational change, as apparent by compar-
ing (Fig. 3) the three-dimensional structure of SERCA1 in
the absence of Ca
2+ (commonly referred to as E2) and in
the presence of bound Ca
2+ (commonly referred to
E1
.Ca2). In fact, calcium binding to the TMBS affects the
A, N and P domain positions in the headpiece, as well as
transmembrane segments. Further conformational changes
occur in parallel with subsequent sequential reactions,
including rotation and bending of entire domains as well
as changes in orientation of side chains involved in
catalysis and binding. This explains the linkage of
phosphoenzyme isomerization to vectorial displacement of
bound Ca
2+ (Toyoshima and Inesi 2004).
A cogent demonstration of the interdependence of Ca
2+
binding, protein conformational change and enzyme acti-
vation is provided by thapsigargin (TG), a very high affinity
and specific inhibitor of Ca
2+ binding and SERCA
activation (Sagara and Inesi 1991). It is shown in Fig. 4
that the presence of TG within the SERCA transmembrane
region produces steric interference (Xu et al. 2004) with
displacement of the Phe256 side chain, which is normally
associated with Ca
2+ binding. Transition from E2 to E1
.Ca2
is thereby prevented, with consequent stabilization of the
E2 conformation, and loss of catalytic activity. It is
noteworthy that single mutations of Phe256 interfere with
the inhibitory effect of TG (Fig. 5).
SERCA is a prominent intracellular protein of muscle,
where it sustains A TP dependent Ca
2+ transport across the
sarcoplasmic reticulum membrane which, in concomitance
with passive release through gated channels, allows
variations of cytosolic Ca
2+ concentrations and control of
Ca
2+ signaling functions (Clapham 2007). A clear example
of the SERCA role in Ca
2+ signaling is observed in cardiac
myocytes (Fig. 6) where specific SERCA inhibition with
TG produces a prominent reduction of Ca
2+ released upon
electrical stimulation, as well as slowing of the decay phase
Fig. 5 Interference of Phe256 mutations with the inhibitory effect of
TG on SERCA1 A TPase activity. Site directerd mutations were
obtained by expression of mutated cDNA delivered by viral vectors
to COS-1 cells. Experiments on A TPase activity were conducted with
the microsomal fraction of the COS-1 cells sustaining heterologous
expression. Derived from Xu et al. (2004)
Fig. 4 Binding of thapsigargin (TG) to SERCA interferes with the E2
to E1.Ca2 transition. TG is shown with van der Waals surface
represented by dotted spheres. Transmembrane portions of M3, M4,
M5, and M7 helices are in violet (E1·2Ca
2+) and in light green (E2
(TG)) and superimposed. Note how steric collisions (dotted circle)
with TG would occur if the F256 side chain would transition from the
E2 state to the E1·2Ca
2+ state in the presence of TG. Derived from Xu
et al. (2004)
Fig. 3 Crystallographic models of SERCA1 in the E2 (left panel) and
E1.Ca2 (right panel) states. The E2 state, stabilized with thapsigargin,
was derived from Protein Data Bank code 1iw0, and the E1.Ca2 state
was derived from Protein Data Bank code 1su4
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2+ signal (Prasad and Inesi 2009). This indicates
that Ca
2+ pumping by SERCA is required to fill the Ca
2+
stores to provide sufficient Ca
2+ for subsequent for release
to activate contraction, and is also required for removal of
cytosolic Ca
2+ to allow decay of the Ca
2+ signal and
relaxation of contraction. It is also shown in Fig. 6 that
heterologous expression of additional SERCA protein by
gene transfer, does not increase the amount of Ca
2+
released, but increases the decay rate of the signal (Cavagna
et al. 2000). This demonstrates that endogenous SERCA is
sufficient to fill the Ca
2+ stores for release of maximal Ca
2+
upon electric stimuli, but the level of endogenous SERCA
is rate limiting for the Ca
2+ signal decay, which can be
accelerated by expression of additional SERCA. Regulation
of SERCA2 activity and level plays important roles in cardiac
physiology and pathology (Bers 2008; Prasad and Inesi
2010). It is of interest that the SERCA affinity for Ca
2+ and
its catalytic turnover can be modulated through phosphory-
lation of the small partner protein phospholamban, in
connection with adrenergic mechanisms in cardiac muscle
(MacLennan and Kranias 2003). Generally, as mentioned
above, the transduction features of Ca
2+ transport A TPases
are basic components of Ca
2+ signaling mechanisms in
numerous and diverse cell systems.
The copper ATPase
The mammalian copper A TPases A TP7A (Dierick et al.
1995; Tümer et al. 1995) and A TP7B (Petrukhin et al. 1994)
encode enzyme isoforms that sustain active transport of
copper by utilization of A TP , and are involved in copper
transfer from enterocytes to blood, copper export from the
liver, copper delivery to the secretory pathways for
incorporation in metalloprotein, and general copper homeo-
stasis as reviewed in detail by Lutsenko et al. (2007).
Genetic defects of A TP7A and A TP7B yield the human
Menkes (Vulpe et al. 1993) and Wilson (Gitlin 2003;
Harada 2002) diseases, respectively.
Structural and functional features of the copper A TPase
proteins have been reviewed (Mercer et al. 2003; Tsivkovskii
et al. 2004;V oskoboinik et al. 2001a), indicating that A TP7A
and A TP7B possess a similar architecture, with considerable
sequence homology but functionally significant differences.
It is shown in Fig. 7 that the A TP7B isoform comprises
eight transmembrane segments (as compared to ten in
SERCA), including a copper binding site (TMBS) involved
in catalytic activation and transport, and a headpiece
including the N, P and A domains with conserved catalytic
motifs analogous to SERCA1. A specific feature of
mammalian copper A TPases is an amino-terminal extension
(NMBD) that includes six copper binding sites in addition to
the TMBS (Lutsenko et al. 2007). This N-terminal extension
is involved in interactions with partner proteins and sustains
copper-induced and functionally relevant conformational
effects (Banci et al. 2009a).
Copper binding is attributed to characteristic CPX or
XPC sequences that are present also in other P1B-type
A TPases involved in transport of other metals such as
cadmium, zinc, lead, cobalt and silver. On the other hand,
other amino acid side chains are likely to participate in
transient metal coordination during transport, thereby
determining metal selectivity (Argüello 2003). Although
the crystal structure of the mammalian copper A TPases is
not available as yet, solution structures of specifc domains
have been obtained by spectroscopic methods (Banci et al.
2009b; Dmitriev et al. 2006). Furthermore, crystal struc-
tures of microbial copper A TPases headpiece domains have
been obtained (Sazinsky et al. 2006a, b; Tsuda and
Toyoshima 2009). Most importantly, the occurrence of
conformational changes concomitant with sequential reac-
tions of the catalytic cycle has been demonstrated by
characterization of proteolytic digestion patterns under
pertinent conditions (Hatori et al. 2009). This indicates
that, in analogy to the calcium A TPase, copper A TPases
undergo functionally related conformational changes.
The native abundance of copper A TPases is quite low
and, for this reason, biochemical experimentation requires
recombinant protein obtained by heterologous expression in
insect or mammalian (Barnes et al. 2005; Tsivkovskii et al.
2002;V oskoboinik et al. 2001b; Pilankatta et al. 2009) cells.
It has been found that the copper A TPase undergoes
phosphorylation upon addition of A TP (Barnes et al. 2005;
Tsivkovskii et al. 2002;V oskoboinik et al. 2001b; Hung et
al. 2007; Pilankatta et al. 2011). It is very important, in this
regard, to distinguish formation of the A TPase catalytic
intermediate from independent kinase assisted phosphory-
lation. In fact, phosphorylation of A TP7B protein (Fig. 8)
Fig. 6 Effects of thapsigargin (TG) and heterologous SERCA
expression (SERCA) on cytosolic Ca
2+ transients of cardiac myocytes
subjected to electrical field stimulation. Myocytes treated with TG
(10 nM) or overexpressing exogenous SERCA following gene transfer
by adenovirus vectors, are compared with control myocytes. Note the
reduction in peak height and decay rate following TG treatment, and
the inreased decay rate following SERA overexpression. Adapted
from Prasad and Inesi (2009) and Cavagna et al. (2000)
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includes a rapid and alkali labile component obtained
within a few seconds, and a much slower alkali resistant
phosphorylation (see below). Only the fast component is
due to formation of phosphorylated intermediate (analogous
to other PA TPases), and is not observed (Fig. 9) following
mutation of the conserved aspartate (D1027) at the catalytic
site, or following mutation within the transmembrane
copper binding site (TMBS). Under optimal conditions,
the phosphoenzyme intermediate undergoes decay by
hydrolytic cleavage within the second time scale, as
expected upon completion of the catalytic site.
Steady state copper transport has been observed with
A TP7A expressed in cultured Chinese hamster ovary cells
(V oskoboinik et al. 1998) and with reconstituted preparations
of A TP7A expressed in insect cells (Hung et al. 2007), but
the reported rates are much lower than expected from A TPase
activity. In fact, measurements of copper transport are
rendered difficult by unfavorable characteristics of the
radioactive copper isotope, as well as by occurrence of
non-specific high affinity copper binding. These difficulties
make it impossible to obtain direct measurements of copper
movements within the short time scale of a single catalytic
cycle, as done in detail for the Ca
2+ A TPase (Fig. 2).
Nevertheless, indirect demonstration of copper movements
was obtained by measurements of charge transfer upon
addition of A TP to A TP7B protein adsorbed on a solid
supported membrane. It is shown in Fig. 10 that, within the
pre-steady state following addition of A TP , a current transient
is in fact obtained, due to movement of positive charge
towards the electrode. The current is not observed in the
presence of copper chelators or following mutation of copper
binding sites in the protein (Tadini-Buoninsegni et al. 2010).
It is of interest that the decay time constant of the copper
signal is 140 +/− 4 milliseconds, which is significantly
slower than that obtained with the Ca
2+ A T P a s e ,i . e .2 5+ / −
0.3 milliseconds under the same conditions (Fig. 10). This
indicates that the catalytic and transport kinetics sustained by
the copper A TPase are approximately one order of magnitude
slower that those of the Ca
2+ A TPase, even though the
general catalytic mechanism retains similar features.
In addition to utilization of A TP for formation of
phosphorylated intermediate, phosphorylation of serine
residues has an influence on trafficking of A TP7A
expressed in both polarized and non-polarized cells
(V eldhuis et al. 2009). Furthermore, it was recently reported
(Pilankatta et al. 2011) that using A TP7B protein expressed
in COS-1 cells, a prominent alkali stable phosphorylation is
obtained following addition of A TP . This alkali stable
phosphorylation is formed at slow rates, in addition to rapid
Fig. 7 Two-dimensional folding model of the A TP7B sequence. The
diagram shows eight transmembrane segments including a copper
binding site (TMBS). Y ellow residues at the TMBS are likely involved
in copper binding. The extramembranous region comprises: a nucleo-
tide binding domain (N) with the H1069 residue whose mutation is
frequently found in the Wilson disease; the P domain, with several
residues (in yellow) conserved in P-type A TPases, where D1027
undergoes phosphorylation to form the catalytic phosphoenzyme
intermediate (EP); the A domain with the TGE (yellow) conserved
sequence involved in catalytic assistance of EP hydrolytic cleavage; the
N-metal binding domain (NMBD) with six copper binding sites; and a
C-terminus chain. Serines undergoing kinase assisted phosphorylation
(Ser478, Ser481, Ser1121 and Ser1453) reside within flexible loops of
the protein
232 G. Inesiformation of alkali labile phosphorylated enzyme intermedi-
ate, and is specifically and totally prevented by protein kinase
D inhibition (Fig. 8). An important feature of Protein kinase
D is its association with the trans-Golgi network, where it
favors fission of transport carriers specifically destined to the
cell surface (V alverde et al. 1994; Liljedahl et al. 2001). It
should be noted that alkali resistant phosphorylation is not
observed at all with the Ca
2+ A TPase (skeletal muscle
SERCA1) under the same conditions (Fig. 8). However,
serine phosphorylation sustained by Ca2+/calmodulin-
dependent protein kinase has been reported for SERCA2,
with consequent activation of Ca
2+ pumping A TPase in
cardiac and slow twitch muscle, but not in fast twitch
skeletal muscle (Hawkins et al. 1994).
Alkali resistant phosphorylation of A TP7B involves
serine residues at least in part identified as S478, S481,
S1121 and S1453 (Fig. 7), requires copper and, most
importantly, is required for A TP7B trafficking. Copper
regulated movement from the Golgi apparatus to vesicles
approaching the plasma membrane was first observed with
A TP7A (Petris et al. 1996, 2002; La Fontaine et al. 1998),
consistent with the notion that copper-induced trafficking of
the copper A TPase is a key mechanism for copper
homeostasis (Mercer et al. 2003). Compartmentalization
and trafficking has also been observed with A TP7B (Guo et
al. 2005; Schaefer et al. 1999). In fact, copper induced
displacement from the trans-Golgi network to cytosolic
Fig. 8 Phosphorylation of WT
A TP7B (a, b), A TP7B D1027N
mutant (c) and WT SERCA1
(d), in the absence (a, c and d)
and in the presence (b) of PKD
inhibitor. Microsomes obtained
from COS-1 cells sustaining
heterologous expression of WT
A TP7B (a, b), A TP7B D1027N
mutant (c), or WT SERCA1 (d)
were incubated with 50 μM
[γ-
32P]A TP at 30°C, in the ab-
sence (a, c and d) or in the
presence (b)o f2 0μM
CID755673 (PKD inhibitor).
Electrophoresis in acid buffer or
alkaline buffer was then per-
formed to distinguish total [
32P]
phosphoprotein (■) from alkali
resistant [
32P]phosphoprotein
(□). The difference is considered
alkali labile [
32P]phosphoprotein
(aspartate: ●) and attributed to
formation of phosphorylated
enzyme intermediate. The stoi-
chiometry of phosphoprotein
refers to total microsomal pro-
tein. Derived from Pilankatta et
al. (2011)
Fig. 9 Copper dependence of A TP7B phosphorylation. and effects of
site directed mutations. Top: Total phosphorylation (aspartate and
serines) is inhibited by copper chelation with BCS. Lower quadrants:
total phosphorylation (aspartate and serines) is prevented by C575A/
C578A mutation at the 6th NMBD copper site (6thCuNMBD mutant),
while only aspartate phosphorylation is prevented by C983A &
C985A mutation of the TMBS (Cu TMBS mutant). Note the different
stoichiometric scale on the vertical axis of the two panels. Derived
from Pilankatta et al. (2011)
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expressed in COS-1 cells (Fig. 11) and hepatocytes
(Tsivkovskii et al. 2002). Most importantly, trafficking is
not observed following mutations within the sixth copper
binding site of the NMBD, or mutation of serines involved
in phosphorylation assisted by protein kinase D (Pilankatta
et al. 2011). It is therefore apparent that a concerted
mechanism, based on copper occupancy of NMBD sites
and kinase assisted phosphorylation of serines, is permis-
sive of A TP7B trafficking. It is possible that the negative
charge acquired by serines through phosphorylation, is
involved in electrostatic interactions (such as arginine
residues) with consequent effects on conformation and
binding to partner proteins. The serine residues undergoing
phosphorylation reside at rather distant locations within the
TP7B sequence (Pilankatta et al. 2009), including the N
terminal extension, the N domain and the C terminal. This
suggests a global conformational response. In fact, a critical
role of the C-terminus has been recently demonstrated
(Braiterman et al. 2011). It is also important to recognize
that a copper and phosphorylation dependent conformation
is required to avoid degradation by proteasome mediated
quality control, and to allow high levels of expressed
A TP7B protein (Pilankatta et al. 2011).
The differential effects of TMBS and NMBD copper
occupancy are of special interest. Mutations within the
transmembrane copper binding site (TMBS) produces
specific inhibition of catalytic phosphorylation (Asp1027)
in analogy to the effect of the calcium TMBS mutations in
the Ca
2+ A TPase. In fact, it was recently proposed that
soluble copper chaperones transfer copper directly to
transmembrane transport sites (González-Guerrero and
Argüello 2008). Furthermore, mutation of the TMBS
copper site does not interfere with kinase assisted phos-
phorylation of serines. On the other hand, mutation of the
sixth NMBD copper site produces inhibition of both
catalytic (aspartate) and kinase assisted (serines) phosphor-
ylation (Fig. 9). It should be pointed out that a functional,
global conformation of A TP7B requires the entire NMBD
segment, since deletion of the segment including the first
five copper NMBD sites results in extensive degradation of
the expressed protein. Levels approximating those obtained
Fig. 11 Heterologous expression, distribution and trafficking of WT
A TP7B in COS-1 cells. COS-1 cells were exposed overnight to
200 μM CuCl2 1 day after infection with adenovirus vector for
delivery of WTA TP7B cDNA. The cells were stained with antibodies
specific for the the Golgi marker protein Giantin (left upper panel),
and the A TP7B c-myc tag (left middle panel) 24 h following infection.
Secondary antibodies yield green color for the A TP7B c-myc tag, and
blue color for Golgi. Red color indicates nuclei stained with
propidium iodide. The lower left panel shows merging of the stains,
demonstrating colocalization of A TP7B with the Golgi marker, in a
distinct and polarized location relative to the nuclei. The right panel
shows an enlarged view of cytosolic vesicles containing A TP7B
(green), budding from the Golgi region (blue) and trafficking
throughout the cytoplasm. Bars: 15 μm. Derived from Pilankatta et
al. (2011)
Fig. 10 Current transients obtained following rapid addition of A TP to
recombinant WTcopper A TPase (in the presence of 5 μMC u C l 2, solid
line)o rC a
2+-A TPase (in the presence of 10 μM free Ca
2+, dotted line).
Charge movements were measured with microsomes containing
recombinant Cu
+-A TPase (A TP7B) or Ca2+ A TPase (SERCA1)
adsorbed on a solid supported membrane anchored to a gold electrode.
No currents are obtained with an inactive A TP7B mutant. Net charge
across the activated protein was compensated for by a flow of electrons
along the external circuit to keep the applied voltage ΔV constant across
the whole metal/solution interphase, and the resulting current transient
was monitored under potentiostatic conditions as a function of time.
This technique detects pre-steady state current transients within the first
transport cycle, and is not sensitive to stationary currents following the
first cycle. (Derived from Tadini-Buoninsegni et al. 2010)
234 G. Inesiwith wild type constructs can be only obtained by specific
inhibition of proteasome mediated degradation but, in this
case, inactive enzyme is produced (Pilankatta et al. 2011). It
is possible that, in various tissues, different requirements
may be involved in conformational mechanisms to allow
interactions with different partner proteins, thereby
accounting for specific trafficking patterns and functions
of copper A TPases. It was reported in this regard that in
polarized hepatic cells, copper response and apical
targeting of A TP7B is only dependent on a short segment
of the NH2-extension rather than the entire NMBD (Guo
et al. 2005). It was proposed that the copper-binding sites
at the N-terminal domain of A TP7A are sensors of low
concentrations of copper but are not essential for the
overall catalytic activity (V oskoboinik et al. 2001c).
Finally, specific sequence features of copper A TPases
may determine diverse behaviors. For instance, the A TP7A
isoform udergoes post-translational glycosylation, while
the A TP7B does not ((Liu et al. 2010) and Fig. 12). This
feature confers plasma membrane stabilization to the
A TP7A isoform (Fig. 13).
Conclusions
Calcium and copper transport A TPases retain an analogous
catalytic mechanism for utilization of A TP , but present a
wide range of differences in the mechanisms of transduc-
tion and signaling. The Ca
2+ A TPase is well characterized
from the structural, biochemical, thermodynamic and
kinetic points of view. It sustains active transport of free
ion across biological membranes, providing Ca
2+ concen-
tration gradients for subsequent release of signaling Ca
2+.
Its conformational states are dictated by occupancy of
calcium, nucleotide and phosphorylation sites specifically
involved in catalysis and active transport. On the other
hand, functionally competent conformation of the copper
A TPase requires proper folding of a rather long NH2-
terminal extension which is not present in the calcium
A TPase. Copper occupancy of the NH2-terminal extension
(NMBD) allows kinase assisted phosphorylation of serine
residues and cytosolic trafficking. Occupancy of the copper
TMBS and of the A TP site on the N domain then triggers
the catalytic cycle. Copper is mostly acquired from, and
delivered to partner proteins.
From a conceptual point of view, transport A TPases have
been viewed as chemiosmotic pumps where A TP utilization
operates, in reverse direction, the mechanism originally
conceived for A TP synthesis in mitochondria (Mitchell
1961). We show here that the Ca
2+ A TPase does in fact
yield a chemiosmotic gradient by active transport of free
Ca
2+. On the contrary, the copperA TPase delivers copper by
active transfer from donors to acceptor proteins. Due to
difficulties in measuring copper binding affinity constants,
we cannot predict the extent of copper ion gradients formed
by the pump. In fact, due to high binding affinity, copper
ion concentrations are expected to remain low. However, we
can conclude that in both calcium and copper A TPases the
A TP chemical energy is utilized to produce specific protein
conformational changes that affect binding affinity and
orientation of specific ligands. Therefore, the common
Fig. 13 Heterologous expression and association of A TP7A protein
with the plasma membrane. COS-1 cells were infected with viral
vectors delivering cDND encoding WT A TP7A with a c-myc tag.
200 μMC u C l 2 was added following the infection. After 24 h, the
cells were fixed with paraformaldehyde and permeabilized with
Triton X-100. Immunostaining of A TP7Awith anti-myc tag antibody
is shown in green (a), and plasma membrane immunostaining with
the anti-PanCadherin antibody is shown in red (b). Nuclear staining
with DAPI is shown in blue (c). The overlay in panel C demonstrates
colocalization of A TP7A and anti-Pan Cadherin antibodies in the
plasma membrane. The bar is 10 μm. Derived from Liu et al. (2010)
Fig. 12 Electrophoretic analysis of A TP7A or A TP7B protein derived
from COS-1 cells sustaining heterologous expression of A TP7A or
A TP7B and purifiedA TP7A protein, and demonstration of A TP7A
glycosylation. COS-1 cells were infected with viral vectors delivering
cDND encoding WTA TP7A or A TP7B with a myc tag. Microsomal or
purified protein stain was stained with Coomassie Blue R-250;
glyocoprotein stain was obtained with Prop Q Emerald 300, and
Western blots were obtained with 9E10 monoclonal antibodies against
the c-myc tag in the expressed protein. D denotes samples that were
subjected to deglycosylation before electrophoresis. Derived from Liu
et al. (2010)
Calcium and copper A TPases: analogies and diversities 235mechanistic feature of transport A TPases is protein confor-
mational work, yielding in some cases an ionic gradient,
and in other cases vectorial displacement of bound ligands
as in the copper A TPase and, even more evidently, in drug
transport A TPases (Ernst et al. 2010).
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